https://www.medtechy.com/the-ticker/articles/2017/can-transe…
Here is an excellent article comparing TRXC’s robot (which actually was their second choice and not what they considered to be their “flagship” robot) with daVinci from ISRG.
ISRG is also bringing out what is expected to be a lower cost model, thus decreasing any pricing advantage that the new robot may have.
daVinci is also working on the same haptic and eye technology. All in all, when you have a complicated product like the daVinci robots that have so embedded themselves into the entire market, the only way that this robot gains any traction at all is to find some niche that ISRG’s products are underserving and TRXC’s robot can better serve. Does it exist? I don’t know, just taking a first look.
From a fundamental perspective this is the issue with TRXC. Is there a niche market/procedure underserved that TRXC can better serve with enough improvement to choose a product other than a ISRG product?
Tinker